U.S. Department of Health and Human Services

Agency for Healthcare Research and Quality (AHRQ) Activities

Quality Improvement/Evidence of Therapy

This section describes current quality improvement and evidence of therapy programs of the Federal government related to chronic kidney disease.

Agency for Healthcare Research and Quality (AHRQ)

AHRQ databases of interest to the kidney community include the Medical Expenditure Panel Survey, Healthcare Cost and Utilization Project, National Guideline Clearinghouse, National ​Quality Measures Clearinghouse, and the Department of Health and Human Services (HHS) Measure Inventory (a repository of measures currently in use across HHS for quality measurement, improvement, and reporting).

AHRQ has established Evidence-Based Practice Centers (EPCs) that produce evidence-based reports and technology assessments on a variety of clinical, behavioral, and organization and financing topics. These evidence reports may be used to inform guidelines, research agendas and quality measures, and serve as the basis for educational materials for consumers, clinicians and policymakers. Recent reports include topics such as contrast-induced nephropathy and calcineurin inhibitors for kidney transplant. Additionally, AHRQ leads the Accelerating Change and Transformation in Organizations and Networks (ACTION III) program. This is a model of field-based research designed to promote innovation in healthcare delivery by accelerating the diffusion of research into practice. AHRQ continues to award extramural research grants to study chronic kidney disease, in areas such as patient safety, disease management and assessment in patients with multiple chronic conditions.

Contact Information
Dina Moss, MPA
ACTIONIII Program Officer
Email: dina.moss@ahrq.hhs.gov

Christine Chang, MD, MPH
Medical Officer, EPC Program
Email: Christine.chang@ahrq.hhs.gov

Last Updated: August 8, 2016

This information was reviewed by KICC agency representatives. It may not reflect new or future agency activities. For more information, please contact the listed representatives.​​​​​​